Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial
| Autor: | Yun Liu, Maolan Li, Fatao Liu, Yingbin Liu, Yongsheng Li, Xu-An Wang, Wenguang Wu, Mao Yang, Yuhao Zhao, Xuya Cui |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | BMJ Open, Vol 13, Iss 2 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2022-0618 2044-6055 |
| DOI: | 10.1136/bmjopen-2022-061892 |
| Popis: | Introduction Gallbladder cancer (GBC) is an aggressive type of digestive system cancer with a dismal outcome. Given the lack of effective treatment options, the disease rapidly reoccurs and 5-year survival rate is |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|